Sarfez Pharmaceuticals, Inc.
Clinical trials sponsored by Sarfez Pharmaceuticals, Inc., explained in plain language.
-
New Slow-Release water pill tested for better fluid control in heart patients
Disease control CompletedThis study tested whether a new extended-release version of the water pill torsemide helps remove more salt and fluid from the body after lunch compared to the standard immediate-release version. Twenty people with stable heart failure who were already taking water pills particip…
Phase: PHASE4 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New pill aims to ease heart failure Patients' urgent bathroom trips
Symptom relief CompletedThis study tested if a new, longer-acting version of a common water pill (torsemide) could better control overactive bladder symptoms like frequent and urgent urination in people with chronic heart failure. It compared this extended-release version against the standard, immediate…
Phase: PHASE2 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test new pill to see how it travels through the body
Knowledge-focused CompletedThis study tested how the body absorbs and processes a new extended-release pill that combines two existing heart medications (torsemide and spironolactone). Researchers enrolled 24 healthy adult volunteers to measure drug levels in their blood and urine over time. The goal was t…
Phase: PHASE3 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Apr 02, 2026 05:42 UTC
-
Scientists test if breakfast changes how your body uses a new heart pill
Knowledge-focused CompletedThis study tested how eating food affects the way the body absorbs a new, combined pill for heart failure. Healthy adult volunteers took the pill once with a high-fat meal and once on an empty stomach. Researchers measured drug levels in blood and urine to see if food changes how…
Phase: PHASE3 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test new Two-in-One heart pill formula
Knowledge-focused CompletedThis study tested a new pill that combines two existing heart medicines (torsemide and spironolactone) into a single, extended-release tablet. Researchers compared how the body absorbs this new combination pill versus taking the two medicines separately. The goal was to see if th…
Phase: PHASE3 • Sponsor: Sarfez Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:08 UTC